Skip to main content
. 2022 May 3;100(2):562–588. doi: 10.1111/1468-0009.12565

Figure 1.

Figure 1

Probability of Medicare Part D Plan Coverage of Nonprotected Drugs According to Drug‐Related Characteristics

Results obtained from enrollment‐weighted multivariable logistic regression analysis, also controlling for approval year and plan type. None of the differences were statistically significant.